Biotech investapalooza continues with more venture rounds for startups; OvaScience cuts half of its workforce (again)
Editor’s note: We here at Endpoints News pride ourselves on providing some comprehensive accounts of all the venture cash flowing into biotech companies, but this week that’s become more than a challenge. In just a matter of three days we’ve fielded news on well over $700 million in venture investments in new and existing life sci companies. And we can’t do a story on each one. So below take a snapshot look at the rest of the companies announcing new raises in the days ahead of JPMorgan. — John Carroll
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
